OncoPharm cover image

Lirafugratinib + LITESPARK011

OncoPharm

00:00

FGFR Inhibitor Responses And Common Toxicities

John Bazar reviews similar response rates across FGFR inhibitors and describes lirafugratinib’s frequent nail, hand-foot, skin, hair, and eye toxicities.

Play episode from 03:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app